Skip to main content

$0.900 0.010 (1.12%)

High

$0.91

Low

$0.88

Trades

38

Turnover

$119,823

Volume

134,901
30 June 2023 at 2:35pm
Register to track EBR and receive email alerts.
Subject
EBR Article: ‘Could be next Cochlear or ResMed’: heart device maker wins FDA approval

EBR Ann: Security Purchase Plan Opens

EBR Ann: Cleansing Notice

EBR Ann: Application for quotation of securities - EBR

EBR Ann: Proposed issue of securities - EBR

EBR Ann: Proposed issue of securities - EBR

EBR Ann: Proposed issue of securities - EBR

EBR Ann: Capital Raising Presentation

EBR Ann: EBR Systems announces a A$35m capital raising

EBR Article: EBR Systems in $30m raise; Wilsons, Bell Potter, Morgans on the ticket

EBR Ann: Trading Halt

EBR Ann: EBR Unlocks Second Tranche of Growth Capital Facility

EBR Ann: CEO Investor Presentation

EBR Ann: Results of 2023 Annual Meeting of Stockholders

EBR Ann: 2023 Annual Meeting Presentation of President & CEO

EBR Article: ‘Next Cochlear’ stock surges after heart device breakthrough

EBR Ann: CEO Presentation on SOLVE-CRT Pivotal Trial Top-line Data

EBR Ann: EBR Reports Positive Results for its Pivotal SOLVE-CRT Trial

EBR Ann: Shareholder and Investor Webinar - SOLVE-CRT Results

EBR Ann: Appendix 4G Updated

EBR Ann: Notice of Annual Meeting of Stockholders and CDI Proxy Form

EBR Ann: Appendix 4G

EBR Ann: Corporate Governance Statement

EBR Ann: Annual Report to Stockholders

EBR Ann: Investor Presentation

EBR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EBR Ann: Notification of cessation of securities - EBR

EBR Ann: Notification regarding unquoted securities - EBR

EBR Ann: EBR Systems to Present at Emergence Conference

EBR Ann: SOLVE-CRT trial data accepted into HRS conference

EBR Ann: Application for quotation of securities - EBR

EBR Ann: EBR confirms no anticipated financial exposure to SVB

EBR Ann: Appendix 3Y

EBR Ann: Appendix 3Y

EBR Ann: EBR Systems Financial Results for FY2022

EBR Ann: Appendix 4E and FY2022 Consolidated Financial Statements

EBR Ann: Appointment of consulting Chief Scientific Officer

EBR Ann: Application for quotation of securities - EBR

EBR Ann: Annual Meeting of Stockholders

EBR Ann: CEO Investor Presentation

EBR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EBR Ann: Notification regarding unquoted securities - EBR

EBR Ann: Notification of cessation of securities - EBR

EBR Ann: EBR shareholder letter and Australian roadshow

EBR Ann: Notification of cessation of securities - EBR

EBR Ann: Application for quotation of securities - EBR

EBR Ann: Application for quotation of securities - EBR

EBR Ann: Notice under ASX Listing Rule 3.10A

EBR Ann: Notification of Change in Auditor

EBR Ann: Notice under ASX Listing Rule 3.10A

Register to track EBR and receive email alerts.